Delivery Order SPE2DB24D8001-SPE2DB24FKZAV

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The $1,261.34 contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The $2,888.62 contract is for the provision of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of September 12, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,906.50, is for the supply of 4.5 mg/0.5 ml Trulicity pens, a medication used to treat diabetes. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., valued at $999,999,999.00, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,896.78, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support medical operations of the U.S. Armed Forces. The contract falls under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,760.74 firm fixed-price contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,608.64 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on June 6, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Trulicity 0.75 mg/0.5 ml pens. The $2,952.18 firm fixed-price contract has a period of performance through February 26, 2025. Dakota Drug, Inc. holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to deliver a range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,960.21, is for the delivery of Trulicity 1.5 mg/0.5 mL pens to support military medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat diabetes. The contract has a total ceiling value of $3,656.14 and a performance period extending through May 5, 2023. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKZAV
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,487.31 contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a medication used to treat diabetes.

The award is issued under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for the U.S. Armed Forces. This IDC positions Dakota Drug as a key supplier of pharmaceutical products and medical supplies to support military medical operations, with a performance period through December 31, 2025. The contract does not have a set-aside designation.

Generated 12/13/24, 9:04 AM